Susquehanna International Group
ALXO icon

Susquehanna International Group’s ALX Oncology ALXO Stock Holding History

Susquehanna International Group’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.6K Buy
19,700
+2,100
+12% +$4K ﹤0.01% 12692
2025
Q4 		$19.9K Buy
+17,600
New +$26.6K ﹤0.01% 11962
2025
Q1 		– Sell
-21,800
Closed -$36.4K – 12395
2024
Q4 		$36.4K Buy
21,800
+11,400
+110% +$17.5K ﹤0.01% 11791
2024
Q3 		$18.9K Sell
10,400
-94,600
-90% -$352K ﹤0.01% 11636
2024
Q2 		$633K Buy
105,000
+93,700
+829% +$1.15M ﹤0.01% 7703
2024
Q1 		$126K Sell
11,300
-42,600
-79% -$598K ﹤0.01% 11059
2023
Q4 		$803K Buy
53,900
+41,600
+338% +$395K ﹤0.01% 7528
2023
Q3 		$59K Buy
12,300
+2,100
+21% +$11.4K ﹤0.01% 11218
2023
Q2 		$76.6K Buy
+10,200
New +$66.8K ﹤0.01% 11128
2022
Q2 		– Sell
-21,300
Closed -$360K – 12803
2022
Q1 		$360K Sell
21,300
-2,000
-9% -$34.1K ﹤0.01% 9811
2021
Q4 		$501K Buy
23,300
+6,700
+40% +$289K ﹤0.01% 9211
2021
Q3 		$1.23M Buy
16,600
+8,800
+113% +$587K ﹤0.01% 7021
2021
Q2 		$427K Buy
7,800
+900
+13% +$53.9K ﹤0.01% 9958
2021
Q1 		$509K Buy
6,900
+2,400
+53% +$189K ﹤0.01% 9424
2020
Q4 		$388K Buy
+4,500
New +$271K ﹤0.01% 8793

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Susquehanna International Group's ALXO Position: Q1 2026 in Review

Susquehanna International Group increased its ALX Oncology (ALXO) stake by 780% in Q1 2026, buying an estimated $2.24M and bringing the position to 1,328,907 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #5525.

Susquehanna International Group first reported a position in ALXO in Q4 2020 and has held it in 20 quarters since. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Susquehanna International Group held 1,328,907 shares of ALX Oncology worth $2.66M as of Q1 2026.
  • Susquehanna International Group bought 1,177,880 ALX Oncology shares in Q1 2026, an estimated $2.24M.
  • ALX Oncology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5525 holding.
  • Susquehanna International Group first reported a position in ALX Oncology in Q4 2020 and has held it in 20 quarters since.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.